IP Library Granted Patent US 10,638,947
Granted Patent B2
US 10,638,947 · App. 14/466,177 · Granted May 5, 2020

Use of electrochemical impedance spectroscopy (EIS) in intelligent diagnostics

Inventors: Andrea Varsavsky (Santa Monica, CA); Michael E. Miller (Culver City, CA); Bradley C. Liang (Bloomfield Hills, MI)
Assignee: MEDTRONIC MINIMED, INC.
A61B5/0537A61B5/0538A61B5/1468A61B5/1473A61B5/1495A61B5/14532A61B5/14865A61B5/7221A61B5/7246A61M5/1582G01N27/026A61B5/6849A61M5/14244A61M5/14276A61M2005/1726
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,638,947
App. No.
14/466,177
Granted
May 5, 2020
Kind
B2
Abstract

Electrochemical Impedance Spectroscopy (EIS) is used in conjunction with continuous glucose monitors and continuous glucose monitoring (CGM) to enable in-vivo sensor calibration, gross (sensor) failure analysis, and intelligent sensor diagnostics and fault detection. An equivalent circuit model is defined, and circuit elements are used to characterize sensor behavior.

Claims (7)

1. A method of differentiating between a first glucose sensor and a second glucose sensor, said first glucose sensor having a configuration that is different from said second glucose sensor, the method comprising:

performing a respective electrochemical impedance spectroscopy (EIS) procedure for each of said first and second glucose sensors;

generating, by a microprocessor, a respective Nyquist plot based on the output of each said respective EIS procedure;

based on said respective Nyquist plots, identifying, by said microprocessor, each of said first glucose sensor and said second glucose sensor;

based on said identification, selecting, by said microprocessor, a first one of a variety of initialization sequences to be applied to said first glucose sensor and a second one of said variety of initialization sequences to be applied to said second glucose sensor; and

applying said first one of said variety of initialization sequences to said first glucose sensor and applying said second one of said variety of initialization sequences to said second glucose sensor, wherein said identification is made based on the lower-frequency Nyquist slope length.

2. The method of claim 1 , wherein said length is calculated as the Cartesian distance between EIS at 0.105 Hz and 1 Hz.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2014
From: VARSAVSKY, ANDREA; MILLER, MICHAEL E.; LIANG, BRADLEY C.
To: MEDTRONIC MINIMED, INC.
Reel/Frame 034179/0779 →
Continuity (2)
Provisional Application 61916637 · Dec 16, 2013
Related Publication 20150164387A1 · Jun 18, 2015
Cited By (1)
US 12,461,050